Scotland's First Minister Nicola Sturgeon met with CMAC researchers at the TIC opening event hosted by Principle Professor Sir Jim McDonald.
The First Minister being shown a demo of continuous manufacturing and crystallisation by CMAC Academic Director Professor Alastair Florence.
The First Minister opening TIC
CMAC has been nominated and short-listed for a Scottish Enterprise Life Sciences Award in the ‘Innovation Award’ category. There are three short-listed finalists in each category, selected by a judging panel which took in November 2014. The winners will be announced at the Scottish Life Sciences Annual Dinner in February 2015. The awards are presented to recognise excellence in companies and individuals who are making a significant contribution to the industry.
CMAC has been awarded circa $1m from the SAVI seed fund including £248K from EPSRC over 3years to support the International Institute for Advanced Pharmaceutical Manufacturing. This is a joint US – UK institute that will bring together world-leading academic expertise to deliver new end-to-end continuous manufacturing capabilities that will transform global supply chain for medicines.
The programme will leverage existing investment in the US and UK, to support an international manufacturing research community. The institute will also engage with regulators to focus research on key targets areas that will maximise impact for end users.
On 20th-21st May 2014, CMAC co-hosted the first International Symposium on Continuous Manufacturing of Pharmaceuticals at MIT, US. This prestigious event was attended by world leaders in continuous processing, with pharmaceutical end users, suppliers, regulators and academics who discussed accelerating adoption of continuous manufacturing for both small molecules and biological products. The key outputs of the meeting were 8 white papers which are due to be published shortly the Journal of Pharmaceutical Science. The final drafts can be found on the website.
The Centre has launched a new Doctoral Training Centre in collaboration with Nanyang Technical University (NTU) Singapore. This graduate training scheme is in addition to the Centre's national EPSRC Doctoral Training Centre (DTC) and is unique in that all students involved will benefit from facilities and training at both the University of Strathclyde and NTU.
As part of an EPSRC Global Engagements award in 2012/ 2013, CMAC established links with Nanyang Technical University (NTU) in Singapore via workshops and exchanges. This year we have built on these links and established the joint doctoral training centre that commenced in October 2014. The first year of this unique scheme commenced with 3 students at University of Strathclyde and 3 at NTU.
Funding Announcement: Digital Design and Manufacture of Amorphous Pharmaceuticals (DDMAP)
CMAC are excited to announce the new £1.2M award from EPSRC to lead the new international collaboration for Digital Design and Manufacture of Amorphous Pharmaceuticals (DDMAP).
This award brings together three world-leading research groups from the UK (CMAC, University of Strathclyde), Denmark (CPHarma, University of Copenhagen) and Belgium (CESPE, Ghent University) to deliver a step change in fundamental understanding of amorphous materials that will apply to real industrial challenges in medicines manufacturing. This unique centre will create a dynamic collaboration across Europe that will embrace open science and offer multi-disciplinary and multi-organisational research engagement. .... more
CMAC Vacancies
CMAC is #hiring! 📢
Do you want to make a difference in the world of #medicinesmanufacturing research? We have some amazing opportunities to join #CMAC, a world leading research centre at the heart of cutting edge innovation.
💊 We are always looking for diverse and inspiring talent
💊 We offer flexible and agile working across our opportunities
💊 We have roles for various skills and career stages
With over 10 vacancies available and more in the pipeline, there has never been a better time to contribute to our broad portfolio of #research, #translation and #skills in award-winning #facilities in #collaboration with global #pharma and technology providers.
.... more